TEVA
Teva Pharmaceutical Industries Limited
TEVA • NYSE
Teva Pharmaceutical Industries Limited is a pharmaceutical preparations company trading on NYSE, led by CEO Richard D. Francis.
CEORichard D. Francis
Next Earnings
Upcoming earnings announcement for Teva Pharmaceutical Industries Limited
Date
Wednesday, May 6, 2026 (in 2 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.54
Revenue Estimate
$3.9B
Earnings History
Past 12 earnings reports for Teva Pharmaceutical Industries Limited
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Jan 28, 2026 | Q4 2025 | $0.96Est: $0.63 | +52.4% | $4.7BEst: $4.3B | +8.8% |  10-K |
| Nov 5, 2025 | Q3 2025 | $0.78Est: $0.67 | +16.4% | $4.5BEst: $4.3B | +3.2% | 10-Q |
| Jul 30, 2025 | Q2 2025 | $0.66Est: $0.61 | +8.2% | $4.2BEst: $4.3B | -1.8% | 10-Q |
| May 7, 2025 | Q1 2025 | $0.52Est: $0.46 | +13.0% | $3.9BEst: $4.0B | -2.5% | 10-Q |
| Jan 29, 2025 | Q4 2024 | $0.71Est: $0.70 | +1.4% | $4.2BEst: $4.1B | +2.6% | 10-K |
| Nov 6, 2024 | Q3 2024 | $0.69Est: $0.66 | +4.5% | $4.3BEst: $4.1B | +5.1% | 10-Q |
| Jul 31, 2024 | Q2 2024 | $0.61Est: $0.55 | +10.9% | $4.2BEst: $4.1B | +2.6% | 10-Q |
| May 8, 2024 | Q1 2024 | $0.48Est: $0.51 | -5.9% | $3.8BEst: $3.7B | +2.4% | 10-Q |
| Jan 31, 2024 | Q4 2023 | $1.00Est: $0.77 | +29.9% | $4.5BEst: $4.0B | +11.1% | 10-K |
| Nov 8, 2023 | Q3 2023 | $0.60Est: $0.61 | -1.6% | $3.9BEst: $3.7B | +3.5% | — |
| Aug 2, 2023 | Q2 2023 | $0.56Est: $0.52 | +7.7% | $3.9BEst: $3.7B | +4.5% | 10-Q |
| May 10, 2023 | Q1 2023 | $0.40Est: $0.56 | -28.6% | $3.7BEst: $3.6B | +0.9% | — |